Destiny Pharma's IPO

Destiny Pharma raised a round of funding on September 05, 2017. Investors include Public.

Destiny Pharma, a clinical stage pharmaceutical company, was founded in 1997. The Company focuses on the R&D of new antimicrobial drugs, with an emphasis on novel mechanisms of action, which seek to a…

Articles about Destiny Pharma's IPO: